drugset / Trial / NCT05741242
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
Phase 1/2
Enrolling by invitation
136 enrolled
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
NaSingle-groupOpen-labelTreatment
Summary
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
Timeline
- Start
- 2022-11-30
- Primary completion
- 2027-01
- Completion
- 2029-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Personalized Synthetic Long Peptide Vaccine | Vaccine | — | — |